Betmiga 50 mg prolonged-release tablets

Company
Astellas Pharma Co. Ltd
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/12/809/008 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/009 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/010 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/011 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/012 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/013 50 Milligram G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/014 50 Milligram G04BD, G04BD12 Prolonged-release tablet
Licence number
EU/1/12/809/008
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/009
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/010
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/011
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/012
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/013
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/014
Strength
50 Milligram
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet

Astellas Pharma Co. Ltd

Damastown Road, Damastown Industrial Park, Mulhuddart, Dublin 15